Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PDE2A | O00408 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24251405 | 0.89 | ROCK2 (0.35) | MEN1KMT2APPARGLMNA | |
| SCHEMBL24251371 | 0.87 | KMT2A (0.41) | MEN1KMT2APPARG | |
| SCHEMBL24251412 | 0.86 | MEN1 (0.46) | MEN1KMT2APDE2ALMNAGAA | |
| SCHEMBL24251556 | 0.85 | PDE2A (0.43) | MEN1KMT2APDE2ALMNAGAA | |
| SCHEMBL24251388 | 0.85 | PDE2A (0.43) | MEN1KMT2APDE2ALMNAGAA | |
| SCHEMBL24251376 | 0.82 | KMT2A (0.39) | MEN1KMT2APPARGLMNA | |
| SCHEMBL24251557 | 0.81 | TSHR (0.48) | MEN1KMT2ALMNAGAA | |
| SCHEMBL24251422 | 0.81 | ALDH1A1 (0.46) | MEN1KMT2APDE2ALMNAGAA | |
| SCHEMBL24251582 | 0.79 | PPARG (0.46) | PPARGPDE2ALMNA | |
| SCHEMBL23355438 | 0.78 | PDE4B (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048903-A1 | Anthelminthic Heterocyclic Compounds | SDHA, PAH, PIGS | MEN1 2676/4885KMT2A 1440/4885PPARG 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.